Cargando…

Liraglutide for weight management: a critical review of the evidence

OBJECTIVE: To review the efficacy, safety, and clinical applicability of liraglutide for weight management from phase III clinical trials. METHODS: A search of the English language literature was performed using PubMed search terms: “liraglutide”, “glucagon‐like peptide‐1 receptor agonist”, and “ran...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mehta, A., Marso, S. P., Neeland, I. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5358074/ https://www.ncbi.nlm.nih.gov/pubmed/28392927 http://dx.doi.org/10.1002/osp4.84

Ejemplares similares

Exposure–response analyses of liraglutide 3.0 mg for weight management
por: Wilding, J. P. H., et al.
Publicado: (2016)

Liraglutide and cardiovascular outcomes in adults with overweight or obesity: A post hoc analysis from SCALE randomized controlled trials
por: Davies, M. J., et al.
Publicado: (2017)

Cardiovascular outcomes in patients who experienced a myocardial infarction while treated with liraglutide versus placebo in the LEADER trial
por: Nauck, Michael A, et al.
Publicado: (2018)

Liraglutide 3.0 mg for Weight Management: A Population Pharmacokinetic Analysis
por: Overgaard, Rune V., et al.
Publicado: (2016)

Real‐World Clinical Effectiveness of Liraglutide 3.0 mg for Weight Management in Canada
por: Wharton, Sean, et al.
Publicado: (2019)

Short-term monotherapy with Liraglutide for weight management: A case study
por: Almarshad, Feras
Publicado: (2019)

The efficacy of liraglutide combined with intragastric balloon on weight loss
por: Yilmaz, Ahmet, et al.
Publicado: (2023)

Liraglutide 3.0 mg for the management of insufficient weight loss or excessive weight regain post‐bariatric surgery
por: Wharton, Sean, et al.
Publicado: (2019)

Liraglutide for Weight Management in Children and Adolescents With Prader–Willi Syndrome and Obesity
por: Diene, Gwenaëlle, et al.
Publicado: (2022)

Case Report: Liraglutide for Weight Management in Beckwith-Wiedemann Syndromic Obesity
por: Caputo, Marina, et al.
Publicado: (2021)

Improvements in health‐related quality of life with liraglutide 3.0 mg compared with placebo in weight management
por: Kolotkin, R. L., et al.
Publicado: (2016)

Liraglutide reduces body weight by upregulation of adenylate cyclase 3
por: Li, Z, et al.
Publicado: (2017)

Managing insulin resistance: role of liraglutide
por: Kalra, Sanjay, et al.
Publicado: (2010)

Long-Term Effectiveness of Liraglutide for Weight Management and Glycemic Control in Type 2 Diabetes
por: Mirabelli, Maria, et al.
Publicado: (2019)

The Efficacy and Safety of Liraglutide 3.0 mg for Weight Management in Obese Non-Diabetic Saudi Outpatients
por: Albaker, Waleed, et al.
Publicado: (2021)

Does Combining Liraglutide with Intragastric Balloon Insertion Improve Sustained Weight Reduction?
por: Mosli, Mahmoud M., et al.
Publicado: (2017)

Real‐world persistence with liraglutide 3.0 mg for weight management and the SaxendaCare® patient support program
por: Wharton, Sean, et al.
Publicado: (2020)

OR33-01 Liraglutide for Weight Management in Pubertal Adolescents with Obesity: A Randomized Controlled Trial
por: Kelly, Aaron S, et al.
Publicado: (2020)

LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations
por: Daniels, G H, et al.
Publicado: (2015)

Neuropsychiatric safety with liraglutide 3.0 mg for weight management: Results from randomized controlled phase 2 and 3a trials
por: O'Neil, Patrick M., et al.
Publicado: (2017)

Liraglutide in the management of type 2 diabetes
por: Wajcberg, Estela, et al.
Publicado: (2010)

Presentation and Management of Liraglutide-Related Pancreatitis: Systematic Review of Case Reports
por: Singh, Som P, et al.
Publicado: (2021)

Liraglutide and polycystic ovary syndrome: is it only a matter of body weight?
por: Pugliese, G., et al.
Publicado: (2023)

A Study on Weight Loss Cause as per the Side Effect of Liraglutide
por: Yu, Jin, et al.
Publicado: (2022)

Efficacy of liraglutide 3.0 mg treatment on weight loss in patients with weight regain after bariatric surgery
por: Muratori, Fabrizio, et al.
Publicado: (2022)

Efficacy and safety of liraglutide in Indian adolescents with obesity
por: Kochar, I. S., et al.
Publicado: (2019)

Chronic intrahypothalamic rather than subcutaneous liraglutide treatment reduces body weight gain and stimulates the melanocortin receptor system
por: Kaineder, K, et al.
Publicado: (2017)

GDF15 acts synergistically with liraglutide but is not necessary for the weight loss induced by bariatric surgery in mice
por: Frikke-Schmidt, Henriette, et al.
Publicado: (2019)

Effects of exenatide and liraglutide on heart rate, blood pressure and body weight: systematic review and meta-analysis
por: Robinson, Louise E, et al.
Publicado: (2013)

Clinical effectiveness of liraglutide vs basal insulin in a real‐world setting: Evidence of improved glycaemic and weight control in obese people with type 2 diabetes
por: Overbeek, Jetty A., et al.
Publicado: (2018)

Efficacy and Safety of Liraglutide and Semaglutide on Weight Loss in People with Obesity or Overweight: A Systematic Review
por: Xie, Zeyu, et al.
Publicado: (2022)

Metformin as an initial adjunct to low-dose liraglutide enhances the weight-decreasing potential of liraglutide in obese polycystic ovary syndrome: Randomized control study
por: JENSTERLE, MOJCA, et al.
Publicado: (2016)

Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults
por: Lean, M E J, et al.
Publicado: (2014)

Effectiveness of Liraglutide in Type II Diabetes Mellitus Management: Experience in Emirati Patients
por: Ghuman, Nasrullah K, et al.
Publicado: (2015)

The potent synergistic effects of the combination of liraglutide and canagliflozin on glycemic control and weight loss
por: Bell, David S.H.
Publicado: (2014)

Comparison between liraglutide alone and liraglutide in combination with insulin on osteoporotic rats and their effect on bone mineral density
por: Chen, Kai, et al.
Publicado: (2021)

Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide
por: Astrup, A, et al.
Publicado: (2012)

Energy intake as a short‐term biomarker for weight loss in adults with obesity receiving liraglutide: A randomized trial
por: Saxena, Aditi R., et al.
Publicado: (2021)

Liraglutide for perioperative management of hyperglycaemia in cardiac surgery patients: a multicentre randomized superiority trial
por: Hulst, Abraham H., et al.
Publicado: (2019)

Liraglutide-Induced Hepatotoxicity
por: Maor, Yaakov, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1lt4ldf6jmir6puplmjj16botg